Publicaciones en las que colabora con Domingo Andres Pascual Figal (38)

2024

  1. Semi-quantitative pulmonary congestion score: prevalence and diuretic management implications after heart failure discharge

    Revista Clinica Espanola, Vol. 224, Núm. 3, pp. 157-161

  2. Withdrawal of drug therapy in responders to cardiac resynchronization therapy: rationale and design of the REMOVE trial

    Revista Espanola de Cardiologia, Vol. 77, Núm. 10, pp. 851-858

2022

  1. Impact on clinical practice of the new SEC consensus to improve lipid control after ACS

    REC: CardioClinics, Vol. 57, Núm. 1, pp. 63-65

  2. Results of a telephone consultation between cardiology and primary care prior to the referral of doubtful cases to hospital emergencies

    Atencion Primaria, Vol. 54, Núm. 6

2021

  1. Usefulness of a smartphone-based event recorder for ambulatory patients with palpitations

    Revista Espanola de Cardiologia, Vol. 74, Núm. 12, pp. 1115-1117

2020

  1. Aortic valve stenosis provides complementary information to bleeding risk scores in non-valvular atrial fibrillation patients initiating anticoagulation

    Journal of Geriatric Cardiology, Vol. 17, Núm. 3, pp. 141-148

  2. Incidence, prognosis and predictors of heart failure after acute myocardial infarction

    REC: CardioClinics, Vol. 55, Núm. 1, pp. 8-14

  3. Incidence, prognosis and predictors of heart failure after acute myocardial infarction

    REC: CardioClinics, Vol. 55, Núm. 1, pp. 8-14

2019

  1. Effect of concomitant antiplatelet therapy in patients with nonvalvular atrial fibrillation initiating non-vitamin K antagonists

    European Journal of Clinical Investigation, Vol. 49, Núm. 10

  2. Effectiveness and safety of rivaroxaban in nonvalvular atrial fibrillation: data from a contemporary Spanish registry

    Current Medical Research and Opinion, Vol. 35, Núm. 8, pp. 1463-1471

  3. Prevalence and Prognostic Implications of Valve Disease in Patients With Atrial Fibrillation Initiating Direct Oral Anticoagulants

    Revista Espanola de Cardiologia, Vol. 72, Núm. 11, pp. 935-943

  4. Real-life behaviour of direct oral anticoagulants in a Spanish cohort with non-valvular atrial fibrillation: Refase Registry

    Current Medical Research and Opinion, Vol. 35, Núm. 12, pp. 2035-2041

2015

  1. Cystatin C-based CKD-EPI equations and N-terminal Pro-B-type natriuretic peptide for predicting outcomes in acutely decompensated heart failure

    Clinical Cardiology, Vol. 38, Núm. 2, pp. 106-113

2013

  1. Comparison of risk prediction with the CKD-EPI and MDRD equations in acute decompensated heart failure

    Journal of Cardiac Failure, Vol. 19, Núm. 8, pp. 583-591

  2. Heart rate control in chronic heart failure: Resting versus mean heart rate with prolonged ambulatory ECG recording

    International Journal of Cardiology, Vol. 170, Núm. 2

  3. Renal function measurements and mortality in patients with acute heart failure

    International Journal of Cardiology, Vol. 168, Núm. 5, pp. 4990-4991

2012

  1. El ancho de distribución eritrocitaria aporta valor pronóstico adicional en pacientes ambulatorios con insuficiencia cardiaca crónica

    Revista Espanola de Cardiologia, Vol. 65, Núm. 7, pp. 606-612

  2. Highly sensitive troponin T for risk stratification of acutely destabilized heart failure

    American Heart Journal, Vol. 163, Núm. 6, pp. 1002-1010

  3. Prognostic significance of long-period heart rate rhythms in chronic heart failure

    Circulation Journal, Vol. 76, Núm. 9, pp. 2124-2129

  4. Prognostic value of serum cystatin C and N-terminal pro b-type natriuretic peptide in patients with acute heart failure

    European Journal of Internal Medicine, Vol. 23, Núm. 7, pp. 599-603